Author:
Curry Jonathan L.,Davies Michael A.,Calderone Tiffany L.,Nathanson Katherine,Prieto Victor G.,Gershenwald Jeffrey E.
Reference38 articles.
1. Davies MA, Gershenwald JE (2010) Targeted therapy for melanoma: a primer. Surg Oncol Clin N Am 20:165–180
2. Wilson M, Zhao F, Letrero R et al (2012) Somatic mutation status of melanomas and effect on clinical outcome in patients on ECOG 2603. Society for Melanoma Research 2012 Congress, Hollywood, CA
3. Becker D, Mihm MC, Hewitt SM et al (2006) Markers and tissue resources for melanoma: meeting report. Cancer Res 66:10652–10657
4. Chapman PB, Hauschild A, Robert C et al (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364:2507–2516
5. Heidorn SJ, Milagre C, Whittaker S et al (2010) Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF. Cell 140:209–221
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献